Gilead’s new HIV med, a bird flu shot for chickens, and Hims does blood tests: Pharma news roundup

The acquisition will unlock a new level of personalized healthcare and deliver integrated offerings across nutrition, lifestyle, supplements, and medication.

Image: Hims & Hers/Business Wire

After having massive success with off-brand weight-loss drugs, the millennial-focused telehealth company Hims & Hers is now expanding its offerings to include at-home blood tests. The company announced today that it has acquired Sigmund NJ, marketed as Trybe Labs, allowing Hims & Hers to offer affordable, at-home blood draws. Through the new tests, customers will be able to get lab work done on a variety of health concerns including hormone levels, cardiac risk, stress markers, cholesterol, liver function, thyroid function, and prostate health.

Gilead’s new HIV med, a bird flu shot for chickens, and Hims does blood tests: Pharma news roundup

Similar Content